These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 11267178)

  • 1. Sirolimus rescue therapy for refractory rejection in renal transplant recipients.
    Hong JC; Kahan BD
    Transplant Proc; 2001; 33(1-2):1033. PubMed ID: 11267178
    [No Abstract]   [Full Text] [Related]  

  • 2. Sirolimus rescue therapy for refractory rejection in renal transplantation.
    Hong JC; Kahan BD
    Transplantation; 2001 Jun; 71(11):1579-84. PubMed ID: 11435968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclosporine elimination in the presence of TOR inhibitors: effects on renal function, acute rejection, and safety.
    Velosa JA; Larson TS; Gloor JM; Stegall MD
    Am J Kidney Dis; 2001 Oct; 38(4 Suppl 2):S3-S10. PubMed ID: 11583938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized trial of three different immunosuppressive regimens to prevent chronic renal allograft rejection.
    Burke GW; Ciancio C; Blomberg BB; Rosen A; Suzart K; Roth D; Kupin W; Esquenazi V; Miller J
    Transplant Proc; 2002 Aug; 34(5):1610-1. PubMed ID: 12176505
    [No Abstract]   [Full Text] [Related]  

  • 5. Better actual 10-year renal transplant outcomes of 80% reduced cyclosporine exposure with sirolimus base therapy compared with full cyclosporine exposure without or with concomittant sirolimus treatment.
    Pliszczynski J; Kahan BD
    Transplant Proc; 2011 Dec; 43(10):3657-68. PubMed ID: 22172822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of sirolimus in combination with low-dose cyclosporine and steroids on acute renal allograft rejection.
    Tsai MK; Chueh SC; Hu RH; Lee PH
    J Formos Med Assoc; 2003 Feb; 102(2):91-6. PubMed ID: 12709737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of Certican (everolimus, rad) in the many pathways of chronic rejection.
    Nashan B
    Transplant Proc; 2001; 33(7-8):3215-20. PubMed ID: 11750380
    [No Abstract]   [Full Text] [Related]  

  • 8. Tacrolimus rescue therapy for renal transplant rejection.
    Jordan ML; Shapiro R; Naraghi R; Smith D; Vivas C; Gritsch HA; Scantlebury V; Randhawa P; Demetris AJ; Fung JJ; Starzl TE
    Transplant Proc; 1996 Aug; 28(4):2119-20. PubMed ID: 8769174
    [No Abstract]   [Full Text] [Related]  

  • 9. Rapamycin in a porcine renal transplant model.
    Almond PS; Moss A; Nakhleh R; Melin M; Chen S; Salazar A; Shirabe K; Matas A
    Transplant Proc; 1993 Feb; 25(1 Pt 1):716. PubMed ID: 8438452
    [No Abstract]   [Full Text] [Related]  

  • 10. Sirolimus antirejection therapy for renal transplantation with cyclosporine-based immunosuppression: case reports.
    Tsai MK; Hu RH; Lee PH
    Transplant Proc; 2003 Feb; 35(1):219-20. PubMed ID: 12591371
    [No Abstract]   [Full Text] [Related]  

  • 11. Design of a trial comparing sirolimus plus mycophenolate mofetil versus sirolimus plus cyclosporine.
    Ponticelli C; Tarantino A; Aroldi A; Sparacino V; Stefoni S; Citterio F; Duca L; Scolari MP; Calabrese S; Altieri P; Civati G; Cesana B
    Transplant Proc; 2003 May; 35(3 Suppl):62S-63S. PubMed ID: 12742469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effectiveness and safety of conversion therapy with the combination of sirolimus with low dose cyclosporine in renal transplantation recipients: a five-year clinical observation].
    Zhu L; Ding T; Wang XX; Lin ZB; Chen G
    Zhonghua Yi Xue Za Zhi; 2016 May; 96(20):1556-61. PubMed ID: 27266681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunosuppression with sirolimus so donor kidneys survive longer].
    MMW Fortschr Med; 2004 Aug; 146(31-32):46-7. PubMed ID: 15529711
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of sirolimus plus tacrolimus versus sirolimus plus cyclosporine in high-risk renal allograft recipients: results from an open-label, randomized trial.
    Gaber AO; Kahan BD; Van Buren C; Schulman SL; Scarola J; Neylan JF;
    Transplantation; 2008 Nov; 86(9):1187-95. PubMed ID: 19005398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of immunosuppressive drugs in the development of tissue-invasive cytomegalovirus infection in renal transplant recipients.
    Kuypers DR; Evenepoel P; Maes BD; Coosemans W; Pirenne J; Vanrenterghem YF
    Transplant Proc; 2002 Jun; 34(4):1164-70. PubMed ID: 12072305
    [No Abstract]   [Full Text] [Related]  

  • 16. Steroid avoidance using sirolimus and cyclosporine in pediatric renal transplantation: one year analysis.
    Iorember FM; Patel HP; Ohana A; Hayes JR; Mahan JD; Baker PB; Rajab A
    Pediatr Transplant; 2010 Feb; 14(1):93-9. PubMed ID: 19254246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early cyclosporine a withdrawal in kidney transplant recipients under a sirolimus-based immunosuppressive regimen: pathological study of graft biopsies at 1-year posttransplant.
    Ruiz JC; Campistol JM; Mota A; Prats D; Gutiérrez A; Castro A; Pinto JR; García J; Morales JM; Grinyo JM; Arias M
    Transplant Proc; 2002 Feb; 34(1):92-3. PubMed ID: 11959199
    [No Abstract]   [Full Text] [Related]  

  • 18. Combined rapamycin and cyclosporine immunosuppression in a porcine renal transplant model.
    Granger DK; Cromwell JW; Canafax DM; Matas AJ
    Transplant Proc; 1996 Apr; 28(2):984. PubMed ID: 8623488
    [No Abstract]   [Full Text] [Related]  

  • 19. A calcineurin antagonist-free induction immunosuppression strategy for delayed graft function in renal transplantation.
    Hong JC; Kahan BD
    Transplant Proc; 2001; 33(1-2):1271-2. PubMed ID: 11267288
    [No Abstract]   [Full Text] [Related]  

  • 20. Conversion to tacrolimus immunosuppression in renal transplant recipients: 12-month follow-up.
    Citterio F; Scatà MC; Romagnoli J; Pozzetto U; Nanni G; Castagneto M
    Transplant Proc; 2002 Aug; 34(5):1685-6. PubMed ID: 12176535
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.